+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Non-tunneled Central Venous Catheter Market by Application (Apheresis, Chemotherapy, Hemodialysis), End User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics), Access Site, Product Type, Material - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6133912
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The field of non-tunneled central venous catheters has become integral to modern clinical practice, underpinning critical interventions across intensive care units, oncology wards, and renal therapy centers. These devices serve as lifelines for patients requiring rapid vascular access for fluid management, parenteral nutrition, chemotherapy, and hemodialysis. As demand for efficient, safe, and durable catheter solutions grows, industry stakeholders are repositioning their strategies to address emerging clinical needs and regulatory priorities.

Against this backdrop, this executive summary delivers a foundational overview and establishes the core objectives driving our strategic insights. Stakeholders will gain a clear understanding of the prevailing market environment, the factors reshaping adoption patterns, and the analytical framework guiding our assessment. By delineating scope, defining key drivers, and articulating critical challenges, this section sets the stage for an in-depth exploration of transformative innovations, tariff impacts, segmentation dynamics, regional developments, and strategic recommendations that follow

Unveiling the Major Transformative Shifts Redefining Non-Tunneled Central Venous Catheter Technologies Clinical Practices and Market Pathways

In recent years, the non-tunneled central venous catheter landscape has witnessed a surge of transformative innovations reshaping clinical protocols and supply chain paradigms. Antimicrobial coatings incorporating silver and chlorhexidine compounds have redefined infection prevention standards, while integrated radiopaque markers and ultrasound-compatible materials enable real-time placement verification. Consequently, clinicians are achieving greater procedural precision and improved patient outcomes, prompting a shift in procurement priorities toward advanced safety features.

Moreover, cross-disciplinary collaborations between medical device manufacturers and digital health firms have fostered the development of remote monitoring platforms that track catheter integrity and patency in real time. As value-based care models gain traction, healthcare providers are increasingly drawn to solutions that demonstrate measurable reductions in catheter-related complications. This convergence of technological innovation, clinical efficacy, and cost containment is forging new pathways for catheter utilization across hemodialysis, oncology infusion, and critical care settings

Examining the Cumulative Impact of Newly Imposed United States Tariffs in 2025 on Supply Chains Regulatory Compliance and Cost Structures

The introduction of newly imposed United States tariffs in 2025 has substantially altered the economic contours of non-tunneled central venous catheter production and distribution. Levies on imported raw materials such as medical-grade polyurethane and silicone have escalated manufacturing costs, compelling device makers to reassess their global sourcing strategies. In turn, procurement teams are negotiating revised supplier agreements, while quality assurance functions ensure that alternative material blends meet stringent biocompatibility and durability standards.

Concurrently, import duties on finished catheter assemblies have led to incremental price adjustments for end users, prompting distributors to reevaluate inventory management and logistics frameworks. To mitigate the cumulative impact of these tariff-driven cost realignments, many organizations are exploring domestic partnerships for polymer extrusion and tubing fabrication. This strategic pivot not only addresses regulatory compliance but also enhances supply chain resilience in the face of potential geopolitical disruptions

Decoding Comprehensive Market Segmentation Insights Across Application End Use Access Site Product Type and Material Categories

A comprehensive understanding of market segmentation reveals critical insights for stakeholders navigating non-tunneled catheter dynamics. Across application segments, therapeutic demand is being driven by increased infusion volumes in chemotherapy and a growing prevalence of renal failure necessitating hemodialysis access. Parenteral nutrition and apheresis procedures also contribute to the overall utilization profile, underscoring the importance of versatile catheter designs that accommodate varying flow rates and lumen configurations.

Within the end user spectrum, hospitals continue to account for a significant share of catheter deployments, with private and public institutions each pursuing distinct procurement criteria based on budget constraints and patient throughput. Ambulatory surgical centers have embraced these devices for outpatient procedures, distinguishing between freestanding facilities and those affiliated with hospital systems. Specialty clinics, notably dialysis centers and oncology practices, have cultivated protocols to streamline vascular access and reduce procedure times, creating opportunities for devices engineered to optimize insertion workflows.

Access site preferences further shape product development priorities, as clinicians weigh the relative merits of the femoral vein, jugular vein, and subclavian vein for specific clinical scenarios. Catheter type also plays a pivotal role, with double lumen configurations favored for simultaneous infusion and monitoring, while single, triple, and quad lumen variants address diverse therapeutic regimens. Material composition is equally consequential: polyurethane remains the standard for its flexibility and wear resistance, whereas silicone formulations are gaining traction for their enhanced biocompatibility and reduced risk of mechanical failure

Highlighting Key Regional Dynamics Shaping the Non-Tunneled Central Venous Catheter Market Trajectory Across the Americas EMEA and Asia-Pacific

Regional dynamics exert a profound influence on how non-tunneled central venous catheters are adopted, regulated, and reimbursed. In the Americas, advanced healthcare infrastructures and favorable reimbursement mechanisms support high-volume use, while ongoing investments in antimicrobial technologies drive competitive differentiation. Market participants must navigate complex coding and billing frameworks to maximize procedural efficiency and cost recovery in both inpatient and outpatient environments.

Europe, the Middle East & Africa display a diverse tapestry of regulatory regimes and hospital procurement processes. European Union directives on medical device classification are harmonizing product registration, whereas Middle Eastern healthcare systems are prioritizing infrastructure expansion and localized manufacturing capabilities. In certain African markets, limited healthcare budgets necessitate strategic partnerships to facilitate catheter availability and clinical training.

In the Asia-Pacific region, rapid economic growth and rising prevalence of chronic diseases underpin increasing demand for vascular access devices. Emerging economies are strengthening regulatory oversight, prompting global suppliers to adapt to local quality standards. At the same time, domestic contract manufacturers are scaling production to serve both regional and international markets, intensifying competition and driving innovation in cost-effective catheter designs

Key Company Strategies and Competitive Movements Driving Innovation Growth and Strategic Partnerships in the Non-Tunneled Central Venous Catheter Sector

Leading participants in the non-tunneled central venous catheter sector are differentiating through targeted investments in research and strategic alliances. Major device manufacturers have expanded their portfolios by acquiring specialty firms with proprietary antimicrobial coatings and advanced polymer processing capabilities. Simultaneously, these leaders are forging collaborations with healthcare networks to pilot next-generation catheter systems and gather real-world performance data.

Mid-tier competitors are capitalizing on niche opportunities by offering customizable solutions tailored to specific clinical protocols, such as high-flow hemodialysis and pediatric oncology infusions. These companies leverage regional sales channels and localized manufacturing footprints to achieve competitive price points while maintaining rigorous quality controls. Partnerships with contract research organizations accelerate product development timelines and support compliance with evolving regulatory standards.

Emerging entrants are differentiating through digital integration, embedding sensors that monitor pressure gradients and detect occlusions in real time. By aligning with telehealth platforms and electronic medical record systems, these innovators are enhancing clinician oversight and fostering preventive maintenance of catheter systems. Such strategic positioning underscores the increasing role of connectivity in driving the next wave of catheter market disruption

Actionable Strategic Recommendations Empowering Industry Leaders to Navigate Market Complexities Enhance Operational Efficiencies and Drive Sustainable Growth

Industry leaders aiming to thrive in this evolving landscape should prioritize accelerated development of antimicrobial and antimicrobial-resistant coatings to minimize infection rates and improve clinical outcomes. Investing in advanced polymer research, including novel silicone blends, will further differentiate product offerings and enhance patient comfort during extended catheterization periods.

Supply chain optimization is equally critical. Establishing strategic alliances with domestic polymer extruders and tubing fabricators can reduce exposure to import tariffs and bolster production agility. In parallel, forging stronger partnerships with ambulatory surgical centers and specialty clinics will enable companies to tailor training programs and procedural workflows, driving faster adoption of innovative catheter systems.

Leaders should also deploy value-based contracting frameworks that align pricing structures with demonstrable quality metrics, such as reduced complication rates and procedural efficiency. By collaborating with payers and healthcare providers to quantify cost savings, manufacturers can secure preferred formulary status and reinforce long-term customer loyalty. Finally, expanding regional manufacturing and distribution networks in high-growth markets will position firms to capture emerging opportunities and fortify competitive barriers

Rigorous Research Methodology Employed to Ensure Data Integrity Robust Analysis and Transparent Insights in the Study of Central Venous Catheters

The analysis underpinning this report is grounded in a rigorous research methodology designed to ensure data integrity and analytical precision. Primary research involved in-depth interviews with key opinion leaders, including interventional radiologists, nephrologists, and procurement executives, providing firsthand perspectives on clinical requirements and buying behaviors. These insights were complemented by consultations with regulatory specialists to assess evolving compliance standards across major jurisdictions.

Secondary research sources included peer-reviewed journals, official regulatory filings, and industry conference proceedings, which were meticulously reviewed to identify emerging trends in catheter materials, coating technologies, and design innovations. Company annual reports, patent databases, and trade publications provided additional context on competitive strategies and product pipelines.

Quantitative analytics were performed using scenario modeling and supply chain mapping techniques to evaluate the impact of tariff changes, production shifts, and regional demand fluctuations. Qualitative frameworks, including SWOT analysis and Porter’s Five Forces, were employed to interpret competitive dynamics and market entry barriers. Together, these methodological pillars create a robust foundation for the insights and recommendations presented

Synthesizing Core Findings and Forward-Looking Perspectives on Non-Tunneled Central Venous Catheter Dynamics in Healthcare Settings

This executive summary synthesizes key findings that illuminate the multifaceted dynamics shaping the non-tunneled central venous catheter market. Technological advancements, highlighted by antimicrobial coatings and real-time monitoring integrations, are setting new benchmarks for patient safety and procedural efficacy. Concurrently, the cumulative effects of US tariffs on raw materials and finished goods have spurred strategic shifts in supply chain configurations and sourcing partnerships.

Segmentation analysis underscores the varied adoption patterns across applications such as chemotherapy, hemodialysis, and parenteral nutrition, while end user preferences reveal growing momentum in ambulatory surgical centers and specialty clinics. Regional insights demonstrate that established markets in the Americas and Europe, the Middle East & Africa maintain robust infrastructure investment, even as Asia-Pacific regions accelerate regulatory enhancements and domestic manufacturing capacity.

Competitive intelligence indicates that leading firms are pursuing acquisitions and digital collaborations to expand their portfolios, while mid-tier and emerging players leverage nimble development cycles and unique product propositions to secure market share. The actionable recommendations presented here offer a strategic roadmap for investment in innovation, supply chain resilience, value-based contracting, and regional expansion. By translating these insights into targeted initiatives, industry participants can address evolving market complexities and achieve sustainable growth

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Apheresis
    • Chemotherapy
    • Hemodialysis
    • Parenteral Nutrition
  • End User
    • Ambulatory Surgical Centers
      • Freestanding
      • Hospital Affiliated
    • Hospitals
      • Private Hospitals
      • Public Hospitals
    • Specialty Clinics
      • Dialysis Centers
      • Oncology Clinics
  • Access Site
    • Femoral Vein
    • Jugular Vein
    • Subclavian Vein
  • Product Type
    • Double Lumen
    • Quad Lumen
    • Single Lumen
    • Triple Lumen
  • Material
    • Polyurethane
    • Silicone
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Becton Dickinson and Company
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Cook Medical LLC
  • ICU Medical, Inc.
  • Smiths Medical
  • Medtronic plc
  • Vygon SA
  • AngioDynamics, Inc.
  • Merit Medical Systems, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of antimicrobial impregnated non-tunneled central venous catheters to reduce infection rates in critical care settings
5.2. Development of ultrasound-guided insertion techniques enhancing safety and success rates of non-tunneled central venous catheter placement
5.3. Integration of wireless monitoring sensors into non-tunneled central venous catheters for real-time hemodynamic data to improve patient outcomes
5.4. Growth in demand for single-lumen non-tunneled central venous catheters in emergency and intensive care units due to simplified protocols
5.5. Increasing regulatory emphasis on safety and standardization of non-tunneled central venous catheter design and material biocompatibility
5.6. Emergence of low-profile dilator systems reducing insertion trauma in pediatric non-tunneled central venous catheter applications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Non-tunneled Central Venous Catheter Market, by Application
8.1. Introduction
8.2. Apheresis
8.3. Chemotherapy
8.4. Hemodialysis
8.5. Parenteral Nutrition
9. Non-tunneled Central Venous Catheter Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.2.1. Freestanding
9.2.2. Hospital Affiliated
9.3. Hospitals
9.3.1. Private Hospitals
9.3.2. Public Hospitals
9.4. Specialty Clinics
9.4.1. Dialysis Centers
9.4.2. Oncology Clinics
10. Non-tunneled Central Venous Catheter Market, by Access Site
10.1. Introduction
10.2. Femoral Vein
10.3. Jugular Vein
10.4. Subclavian Vein
11. Non-tunneled Central Venous Catheter Market, by Product Type
11.1. Introduction
11.2. Double Lumen
11.3. Quad Lumen
11.4. Single Lumen
11.5. Triple Lumen
12. Non-tunneled Central Venous Catheter Market, by Material
12.1. Introduction
12.2. Polyurethane
12.3. Silicone
13. Americas Non-tunneled Central Venous Catheter Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Non-tunneled Central Venous Catheter Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Non-tunneled Central Venous Catheter Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Becton Dickinson and Company
16.3.2. Teleflex Incorporated
16.3.3. B. Braun Melsungen AG
16.3.4. Cook Medical LLC
16.3.5. ICU Medical, Inc.
16.3.6. Smiths Medical
16.3.7. Medtronic plc
16.3.8. Vygon SA
16.3.9. AngioDynamics, Inc.
16.3.10. Merit Medical Systems, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NON-TUNNELED CENTRAL VENOUS CATHETER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NON-TUNNELED CENTRAL VENOUS CATHETER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. NON-TUNNELED CENTRAL VENOUS CATHETER MARKET: RESEARCHAI
FIGURE 26. NON-TUNNELED CENTRAL VENOUS CATHETER MARKET: RESEARCHSTATISTICS
FIGURE 27. NON-TUNNELED CENTRAL VENOUS CATHETER MARKET: RESEARCHCONTACTS
FIGURE 28. NON-TUNNELED CENTRAL VENOUS CATHETER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APHERESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APHERESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY FREESTANDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY FEMORAL VEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY FEMORAL VEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY JUGULAR VEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY JUGULAR VEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SUBCLAVIAN VEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SUBCLAVIAN VEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY DOUBLE LUMEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY DOUBLE LUMEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY QUAD LUMEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY QUAD LUMEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY TRIPLE LUMEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY TRIPLE LUMEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SILICONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 105. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 110. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 111. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 112. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 113. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 114. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 115. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 116. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 117. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 120. CANADA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 121. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 136. MEXICO NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 203. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 214. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 215. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 218. GERMANY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 219. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 230. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 231. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 234. FRANCE NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 251. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 256. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 257. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 258. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 259. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 260. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 261. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 262. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 263. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 266. ITALY NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 267. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 272. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 273. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 278. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 279. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 282. SPAIN NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES NON-TUNNELED CENTRAL VENOUS CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES NON-TUNNELED CENTRAL VENOUS CATHE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Non-tunneled Central Venous Catheter market report include:
  • Becton Dickinson and Company
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Cook Medical LLC
  • ICU Medical, Inc.
  • Smiths Medical
  • Medtronic plc
  • Vygon SA
  • AngioDynamics, Inc.
  • Merit Medical Systems, Inc.